Product Information
DARIFENACIN ER 7.5 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.5494 per EA under NDC 62332022330. Its NADAC has been published 120 times since Jun 19, 2024.
FDA first approved this application on Dec 8, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
7.5 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332022330
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DARIFENACIN HYDROBROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207681FDA Approved
12/8/2017
TE Code
AB
On Market Since
12/12/2017
Pharmacological Classes
Price Statistics
The NADAC for DARIFENACIN ER 7.5 MG TABLET has been published 120 times since Jun 19, 2024, and over the history we have for it it has declined 53.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5494 per EA |
|---|---|
| All-time high | $1.1895 (Jul 10, 2024) |
| All-time low | $0.5115 (Aug 20, 2025) |
| 52-week high | $0.7315 |
| 52-week low | $0.5331 |
| Median price | $0.5995 |
| Average price | $0.6463 |
| Largest weekly change | -37.2% (Jul 17, 2024) |
| Weeks tracked | 120 |
| Tracking since | Jun 19, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
DARIFENACIN market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinergic Muscarinic Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DARIFENACIN ER 7.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DARIFENACIN ER 7.5 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.5494 per EA (NDC 62332022330), effective Sep 30, 2026.
How has the price of DARIFENACIN ER 7.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for DARIFENACIN ER 7.5 MG TABLET has declined 53.8%. It has been tracked across 120 weekly CMS publications since Jun 19, 2024.
What are the highest and lowest recorded NADAC prices for DARIFENACIN ER 7.5 MG TABLET?
Since Jun 19, 2024, the NADAC for DARIFENACIN ER 7.5 MG TABLET has ranged from a low of $0.5115 (Aug 20, 2025) to a high of $1.1895 (Jul 10, 2024), with a median of $0.5995 per EA.
Are there cheaper alternatives to DARIFENACIN ER 7.5 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DARIFENACIN ER 7.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures DARIFENACIN ER 7.5 MG TABLET?
DARIFENACIN ER 7.5 MG TABLET (NDC 62332022330) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.